Skip to content

10-KAccepted Mar 19, 7:10 AM ET

Acrivon Therapeutics, Inc. 10-K

ACRVAcrivon Therapeutics, Inc.

Accepted (ET)

7:10 AM

Mar 19, 2026

Filed

Mar 19, 2026

Documents

91

Size

12.4 MB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.